Close Menu

Almac

The Craigavon, UK-based company said that it opened the facility in response to an increase in the number of clinical trial-related projects it has commenced with biopharmaceutical companies.

The two companies announced plans to develop a companion diagnostic to predict whether non-squamous non-small cell lung cancer patients can benefit from combination treatment with Alimta and cisplatin based on the thymidylate synthase biomarker.

Almac and Lilly will study a predictive marker for use as a companion diagnostic for a combination therapy.

Austin Tanney, Almac Diagnostics' scientific liaison manager, said this week that any markers identified at the University of Miami will be in the hands of the researchers, but should panels with diagnostics potential be discovered, Almac will consult with the university to commercialize them.

The school will use the company's cancer diagnostic microarray to study ethnic differences in breast cancer.

Pages

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.